Pitcairn CO Evotec Se Transaction History
Pitcairn CO
- $1.5 Billion
- Q2 2025
A detailed history of Pitcairn CO transactions in Evotec Se stock. As of the latest transaction made, Pitcairn CO holds 261,181 shares of EVO stock, worth $995,099. This represents 0.07% of its overall portfolio holdings.
Number of Shares
261,181
Previous 21,892
1093.04%
Holding current value
$995,099
Previous $91,000
1104.4%
% of portfolio
0.07%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EVO
# of Institutions
37Shares Held
3.55MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA1.21MShares$4.59 Million0.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT1.11MShares$4.25 Million2.33% of portfolio
-
Morgan Stanley New York, NY385KShares$1.47 Million0.0% of portfolio
-
Wcm Investment Management, LLC Laguna Beach, CA298KShares$1.14 Million0.0% of portfolio
-
Envestnet Asset Management Inc91.7KShares$349,2390.0% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.35B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...